| 发明名称 | Pharmaceutical formulation comprising a phosphodiesterase inhibitor | ||
| 摘要 | Pharmaceutical formulations to be administered by pressurized metered dose inhalers (pMDIs), comprising a compound of general formula (I) may be used for the treatment and/or prevention of inflammatory or obstructive airway diseases. | ||
| 申请公布号 | US9358224(B2) | 申请公布日期 | 2016.06.07 |
| 申请号 | US201113195903 | 申请日期 | 2011.08.02 |
| 申请人 | CHIESI FARMACEUTICI S.p.A. | 发明人 | Bonelli Sauro;Losi Elena;Zambelli Enrico |
| 分类号 | A61K9/12;A61K31/435;C07D211/82;A61K31/44;A61K9/00 | 主分类号 | A61K9/12 |
| 代理机构 | Oblon, McClelland, Maier & Neustadt, L.L.P. | 代理人 | Oblon, McClelland, Maier & Neustadt, L.L.P. |
| 主权项 | 1. A pharmaceutical formulation for aerosol administration, comprising: (a) the (−) enantiomer of 3-cyclopropylmethoxy-4-methanesulfonylaminobenzoic acid 1-(3-cyclopropylmethoxy-4-difluoromethoxyphenyl)-2-(3,5-dichloro-1-oxypyridin-4-yl)ethyl ester; (b) a propellant; (c) a co-solvent; and (d) a surfactant selected from the group consisting of a PEG surfactant, a PVP surfactant, and a mixture thereof. | ||
| 地址 | Parma IT | ||